Show simple item record

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

dc.contributor.authorBergh, J
dc.contributor.authorPritchard, KI
dc.contributor.authorSwain, S
dc.contributor.authorCameron, D
dc.contributor.authorAlbain, K
dc.contributor.authorAnderson, S
dc.contributor.authorArriagada, R
dc.contributor.authorBartlett, J
dc.contributor.authorBergsten-Nordstrom, E
dc.contributor.authorBliss, J
dc.contributor.authorBradley, R
dc.contributor.authorBrain, E
dc.contributor.authorBraybrooke, J
dc.contributor.authorCarey, L
dc.contributor.authorClarke, M
dc.contributor.authorColeman, R
dc.contributor.authorCuzick, J
dc.contributor.authorDavidson, N
dc.contributor.authorDel Mastro, L
dc.contributor.authorDi Leo, A
dc.contributor.authorDignam, J
dc.contributor.authorDodwell, D
dc.contributor.authorDowsett, M
dc.contributor.authorDuane, F
dc.contributor.authorEjlertsen, B
dc.contributor.authorFrancis, P
dc.contributor.authorGelber, R
dc.contributor.authorGnant, M
dc.contributor.authorGoetz, M
dc.contributor.authorGoodwin, P
dc.contributor.authorGray, R
dc.contributor.authorHalpin-Murphy, P
dc.contributor.authorHayes, D
dc.contributor.authorHill, C
dc.contributor.authorJagsi, R
dc.contributor.authorJanni, W
dc.contributor.authorLiu, Z
dc.contributor.authorLoibl, S
dc.contributor.authorMacKinnon, E
dc.contributor.authorMamounas, E
dc.contributor.authorMannu, G
dc.contributor.authorMartin, M
dc.contributor.authorMcGale, P
dc.contributor.authorMukai, H
dc.contributor.authorNekljudova, V
dc.contributor.authorNorton, L
dc.contributor.authorOhashi, Y
dc.contributor.authorPan, H
dc.contributor.authorPeto, R
dc.contributor.authorPiccart, M
dc.contributor.authorPierce, L
dc.contributor.authorPoortmans, P
dc.contributor.authorRaina, V
dc.contributor.authorRea, D
dc.contributor.authorRegan, M
dc.contributor.authorRobertson, J
dc.contributor.authorRutgers, E
dc.contributor.authorSlamon, D
dc.contributor.authorSpanic, T
dc.contributor.authorSparano, J
dc.contributor.authorSteger, G
dc.contributor.authorTaylor, C
dc.contributor.authorTang, G
dc.contributor.authorToi, M
dc.contributor.authorTutt, A
dc.contributor.authorViale, G
dc.contributor.authorWang, X
dc.contributor.authorWhelan, T
dc.contributor.authorWilcken, N
dc.contributor.authorWolmark, N
dc.contributor.authorColla, EBCT
dc.date.accessioned2021-10-28T08:48:11Z
dc.date.available2021-05-07
dc.date.available2021-10-28T08:48:11Z
dc.date.issued2021-08
dc.identifier.issn1470-2045
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/74783
dc.format.extent1139 - 1150
dc.relation.ispartofLANCET ONCOLOGY
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleTrastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trialsen_US
dc.typeArticleen_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000684199600034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue8en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume22en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States